Clinical trial
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.
NCT00432263 · Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00432263 |
|---|---|
| Title | Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury. |
| Official title | Placebo-Controlled Trial On The Efficacy Of Growth Hormone Replacement Therapy In Patients With Growth Hormone Deficiency After Traumatic Brain Injury |
| Lead sponsor | Pfizer, Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Brain Injuries |
| Intervention type | Drug |
| Interventions | Genotropin (PN-180, 307) Somatropin |
| Enrollment | 0 |
| Start date | Apr 1, 2007 |
| First posted | Feb 7, 2007 |
| Last update posted | Apr 22, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: